Suppr超能文献

Early iron overload in beta-thalassaemia major: when to start chelation therapy?

作者信息

Fargion S, Taddei M T, Gabutti V, Piga A, Di Palma A, Capra L, Fontanelli G, Avanzini A

出版信息

Arch Dis Child. 1982 Dec;57(12):929-33. doi: 10.1136/adc.57.12.929.

Abstract

Twenty-eight children with beta-thalassaemia major aged between 11 and 48 months were given intensive transfusions. Serum iron, transferrin saturation, serum ferritin, non-transferrin iron, and subcutaneous desferrioxamine-induced urinary iron excretion were measured. The results showed that even children with a limited number of transfusions had severe iron overload as indicated, in particular, by the raised serum ferritin levels and the high excretion rates after subcutaneous infusion of desferrioxamine. The desferrioxamine test was useful, even in very young children, in assessing response to chelation therapy thus enabling such treatment to be started early to prevent harm from iron overload.

摘要

相似文献

1
Early iron overload in beta-thalassaemia major: when to start chelation therapy?
Arch Dis Child. 1982 Dec;57(12):929-33. doi: 10.1136/adc.57.12.929.
2
Iron overload and desferrioxamine chelation therapy in beta-thalassemia intermedia.
Eur J Pediatr. 1981 Nov;137(3):267-71. doi: 10.1007/BF00443255.
3
Prevention of iron loading in transfusion-dependent thalassaemia.
Lancet. 1978 Jun 3;1(8075):1178-81. doi: 10.1016/s0140-6736(78)90968-6.
4
Urinary iron excretion induced by intravenous infusion of deferoxamine in beta-thalassemia homozygous patients.
Braz J Med Biol Res. 2002 Nov;35(11):1319-28. doi: 10.1590/s0100-879x2002001100009.
6
Effective chelation of iron in beta thalassaemia with the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one.
Br Med J (Clin Res Ed). 1987 Dec 12;295(6612):1509-12. doi: 10.1136/bmj.295.6612.1509.
9
Oral deferiprone for iron chelation in people with thalassaemia.
Cochrane Database Syst Rev. 2007 Jul 18(3):CD004839. doi: 10.1002/14651858.CD004839.pub2.
10
Ascorbic acid enhancement of desferrioxamine-induced urinary iron excretion in thalassemia major.
Ann N Y Acad Sci. 1974;232(0):221-5. doi: 10.1111/j.1749-6632.1974.tb20588.x.

引用本文的文献

1
Physiology and pathophysiology of iron in hemoglobin-associated diseases.
Free Radic Biol Med. 2014 Jul;72:23-40. doi: 10.1016/j.freeradbiomed.2014.03.039. Epub 2014 Apr 12.
2
Evaluation of growth, puberty and endocrine dysfunctions in relation to iron overload in multi transfused Indian thalassemia patients.
Indian J Pediatr. 2011 Jun;78(6):679-83. doi: 10.1007/s12098-010-0351-3. Epub 2011 Jan 14.
4
Clinical applications of commonly used contemporary antidotes. A US perspective.
Drug Saf. 1997 Jan;16(1):9-47. doi: 10.2165/00002018-199716010-00002.
5

本文引用的文献

2
A non-transferrin-bound serum iron in idiopathic hemochromatosis.
Dig Dis Sci. 1980 May;25(5):340-6. doi: 10.1007/BF01308057.
4
Survival and desferrioxamine in thalassaemia major.
Br Med J (Clin Res Ed). 1982 Apr 10;284(6322):1081-4. doi: 10.1136/bmj.284.6322.1081.
6
Long-term desferrioxamine therapy in thalassemia.
Ann N Y Acad Sci. 1974;232(0):201-10. doi: 10.1111/j.1749-6632.1974.tb20586.x.
7
Reassessment of the use of desferrioxamine B in iron overload.
N Engl J Med. 1976 Jun 24;294(26):1421-3. doi: 10.1056/NEJM197606242942603.
10
Continuous subcutaneous administration of deferoxamine in patients with iron overload.
N Engl J Med. 1977 Aug 25;297(8):418-23. doi: 10.1056/NEJM197708252970804.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验